Venous Support Ingredients & Drug Interactions
by Progressive Professional from Progressive Laboratories
What is this page for?
First and foremost: checking Venous Support against your medications. The heart of this page is the interaction checker and the full interaction report — how this product’s ingredients may interact with prescription and over-the-counter medicines you may be taking.
Around that, we add a pharmacist’s high-level view of the product as a whole — what’s inside, the evidence for its stated use, how transparent the label is, and what safety data exists — so you can see the full picture in one place. It’s educational information from our licensed clinical databases and the clinical staff at HelloPharmacist — not medical advice — and we don’t sell or endorse products. Our editorial policy
Venous Support is a dietary supplement by Progressive Professional from Progressive Laboratories with 3 active ingredients. Its ingredients are commonly taken for heart health, high blood pressure, high cholesterol.Based on those ingredients, 1,140 medications have a known interaction with it, the most serious rated moderate. The ingredients most likely to interact are Diosmin, Hesperidin. Use the checker below to test your specific medication, or read the full HelloPharmacist Interaction Report.
Check Your Meds Against Venous Support by Progressive Professional from Progressive Laboratories
Ask about any prescription or over-the-counter medication and we check it for interactions with Venous Support by Progressive Professional from Progressive Laboratories — and tell you which ingredient is responsible.
AI summaries are generated from our interaction database for education only — always confirm with your pharmacist. How we use AI
Ask the Pharmacist
A licensed pharmacist will answer your question by email — free, usually within 24 hours.
Got it — thank you!
A licensed pharmacist will answer within 24 hours. Keep an eye on your email (worth checking spam, just in case).
HelloPharmacist Scorecard of Venous Support by Progressive Professional from Progressive Laboratories
Our pharmacy team’s full take, with four database checks built into the cards below — a summary of what is known, not a grade of the product itself.
What’s inside
Full disclosure
Venous Support contains three active ingredients. Diosmin, a plant compound called a bioflavonoid, is the main ingredient and is used to support healthy circulation and strengthen blood vessel function.
Hesperidin, another bioflavonoid, works alongside diosmin. Olive leaf extract rounds out the formula.
The product also contains inactive ingredients — hydroxypropyl methylcellulose and leucine — which are fillers and binders that hold the capsule together.
Does it work?
Moderate evidence
The evidence supporting these ingredients is mixed. Diosmin is rated possibly effective for chronic venous insufficiency (heaviness or swelling in the legs from poor circulation) and venous leg ulcers, as well as hemorrhoids.
For hesperidin and olive leaf extract, we don't have enough reliable evidence in our data to say whether they work for their intended purposes. Hesperidin is rated possibly ineffective for weight loss and cholesterol levels.
How safe is it?
Well-documented data
Diosmin is generally well tolerated in the short term, though long-term safety isn't well studied. The most common side effects are abdominal pain, diarrhea, dizziness, nausea, stomach inflammation, and skin irritation.
Rare serious effects include irregular heartbeat and hemolytic anemia (a type of blood disorder). Olive leaf extract seems well tolerated, with the main reported side effects being headache and stomach discomfort — a small number of people reported acne.
Hesperidin is generally well tolerated in food amounts and short-term use, though one case of allergic skin reaction was reported. Safety data for diosmin in pregnancy and lactation are mixed (rated possibly safe to likely safe); for hesperidin, the data suggest avoiding it during pregnancy and breastfeeding due to insufficient information.
We hold no pregnancy or lactation data for olive leaf extract.
Meds to double-check
Moderate interaction found
Before taking Venous Support, double-check if you're on blood thinners or blood-clotting prevention drugs (anticoagulants or antiplatelets) — diosmin has been linked to serious bleeding in at least one case. Also verify any pain relievers, muscle relaxants, seizure medications, blood pressure medications, or heart drugs you take, as diosmin and hesperidin may affect how your liver processes them or change their effectiveness.
If you're unsure whether your medications fall into these categories, run them through the checker below.
The bottom line
Scorecard at a glanceFully disclosed formula with some supporting evidence for its stated purpose. Moderate medication interactions have been identified, and safety information is well characterized.
This product is designed to support healthy circulation and venous function, with diosmin as its main active ingredient. If you take blood thinners, seizure medications, pain relievers, blood pressure drugs, heart medications, or muscle relaxants, you need to check with us or your pharmacist before starting — the interaction risks are real.
Even if you don't take prescription medications, it's worth discussing with your doctor if you're pregnant or nursing.
Educational only — not medical advice; always confirm with your pharmacist. Our editorial policy · How we use AI
Assessment coverage: 3 of 3 active ingredients matched to our full ingredient reviews (monographs). Based on the product label dated Apr 11, 2022.
This Scorecard evaluates available label information, ingredient evidence, and known medication-safety considerations. It does not independently verify product identity, purity, potency, contamination, or manufacturing quality. How these ratings are computed
General information
Key facts about Venous Support, straight from the product label.
| Brand | Progressive Professional from Progressive Laboratories |
|---|---|
| Barcode (UPC) | 351821010335 |
| Net contents | 90 Vegetable Capsule(s) |
| Market status | On market |
| Date entered into DSLD | Apr 11, 2022 |
| DSLD ID | 261309 |
| Product type | Other Combinations |
| Supplement form | Capsule |
| Dietary claims / uses | All Other, Structure/Function |
| Intended target group(s) | Adult (18 - 50 Years) |
Everything in this section is reproduced from the manufacturer’s own product label — it’s the label speaking, not HelloPharmacist. We show it so you can see exactly what the maker states; we don’t verify or endorse those statements.
Supplement Facts
The label details for Venous Support by Progressive Professional from Progressive Laboratories, sourced from the NIH Dietary Supplement Label Database.
Supplement Facts
| Ingredient | Amount | % DV |
|---|---|---|
| Olive leaf extract | 100 mg | -- |
| Diosmin | 300 mg | -- |
| Hesperidin | 40 mg | -- |
Other ingredients: Hydroxypropyl Methylcellulose, Leucine
Tap any ingredient to jump to its full detail below.
These statements are the manufacturer’s wording, reproduced from the product label — the label is saying it, not HelloPharmacist. We don’t verify or endorse them.
Suggested/Recommended/Usage/Directions
Directions: Take one vegetable capsule three times daily preferably with meals, or as directed by a health care professional.
Precautions
Sold only for dispensing by a licensed health care professional.
Tamper evident band around cap and seal on bottle. Do not use if either seal is broken or missing.
Keep out of reach of children.
Patients taking prescription medications should consult their physician for possible interactions. Warning: Pregnant or lactating women, or people taking medications, should consult their healthcare provider prior to taking any supplements.
FDA Disclaimer Statement
This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
Formulation
Progressive Laboratories manufactured this product in its 3rd party GMP-inspected facility. (Good Manufacturing Practices)
Seals/Symbols
GMP Good Manufacturing Practice Certified GMP Compliant 21 CFR 111
Brand IP Statement(s)
Progressive Professional from Progressive Laboratories
FDA Statement of Identity
Dietary Supplement
Is this label outdated? Report a formula or label change and our pharmacy team will review it.
Venous Support by Progressive Professional from Progressive Laboratories label
The label scan from the NIH Dietary Supplement Label Database. Tap to enlarge.
Label images are published by the NIH Dietary Supplement Label Database for the version of this product on file. Always read your actual product label.
View the full label (PDF)The Ingredients in Venous Support by Progressive Professional from Progressive Laboratories
These are the 3 active ingredients this product is made of. Select any to open its full monograph.
Serving size1 Vegetable Capsule(s) Dosage formCapsule Servings per container90 Amounts shown are per serving.
Most supplement products combine several ingredients, and a medication can interact with the product through any one of them. Each ingredient below shows whether it has known drug interactions.
Olive leaf extract
No knowninteractions
Olive comes from the same tree that gives us olives and olive oil, and its leaf and fruit contain antioxidant compounds like oleuropein and hydroxytyr...
Olive leaf extract monograph & interactionsDiosmin
Interacts with884 drugs
Diosmin is a citrus-derived flavonoid most often used for vein-related problems such as chronic venous insufficiency and hemorrhoids, and it is usuall...
Diosmin monograph & interactionsHesperidin
Interacts with702 drugs
Hesperidin is a flavonoid found in citrus fruits that is often combined with diosmin and used for vein and circulation problems like hemorrhoids and v...
Hesperidin monograph & interactionsOther (inactive) ingredients: Hydroxypropyl Methylcellulose, Leucine. These complete the product’s ingredient list but are not active constituents.
Venous Support by Progressive Professional from Progressive Laboratories Drug Interactions
HelloPharmacist Interaction Report
Venous Support from Progressive Professional has documented interactions with a large number of medications, primarily through its diosmin and hesperidin content.
The most serious finding involves diosmin and blood thinners (anticoagulants) or blood-clotting prevention drugs (antiplatelet agents) — a case of life-threatening bleeding in the brain has been reported when diosmin was combined with warfarin and aspirin. If you take any of these drugs, you'll need to check with us before starting.
Read the full breakdown — every affected drug type, severity by severity
Diosmin interacts with several groups of medications by affecting how your liver breaks them down. It can raise levels of pain relievers like diclofenac, muscle relaxants like chlorzoxazone, and seizure medications like carbamazepine — potentially increasing their effects or side effects.
It may also affect how your body handles drugs processed through specific liver pathways (CYP2C9, CYP3A4, and CYP2E1 substrates) and drugs moved by a cellular pump called P-glycoprotein.
Hesperidin adds concerns with blood pressure medications (antihypertensives), sedating drugs (CNS depressants), and heart medications like verapamil and diltiazem — it may boost their effects. It also theoretically increases bleeding risk with blood thinners and antiplatelet drugs.
Hesperidin may reduce the effectiveness of celiprolol, a beta-blocker.
Olive leaf extract was checked and has no interactions documented in our data — though this doesn't guarantee none exist. Altogether, these interactions span 1,126 individual medications.
Use the medication checker on this page to verify your exact prescriptions before you begin.
Check your own medications below · Editorial policy · How we use AI
Want to check YOUR meds against Venous Support?
Ask about interactions with your drugs in plain English — “Can I take it with lisinopril?” — and we find you the answer in seconds, ingredient by ingredient.
Go to the checkerIngredients driving the most interactions
Individual Drug Interactions
The ingredients in Venous Support interact with 1,140 drugs. Click any drug to see the details.
2 of the 3 ingredients in Venous Support interact with drugs. Each result below shows which ingredient is responsible. Diosmin Hesperidin
Ado-trastuzumab EmtansineKadcyla
How Ado-trastuzumab Emtansine interacts with Venous Support — through 1 ingredient. Tap an ingredient for the detail:
DiosminCytochrome P450 3a4 (cyp3a4) Substrates Moderate
Interaction Summary
Theoretically, diosmin might inhibit the metabolism of CYP3A4 substrates.
Read the full Diosmin + Ado-trastuzumab Emtansine interactionAbciximabReoPro
How Abciximab interacts with Venous Support — through 2 ingredients. Tap an ingredient for the detail:
HesperidinAnticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Theoretically, hesperidin may increase the risk of bleeding if used with anticoagulant or antiplatelet drugs.
Read the full Hesperidin + Abciximab interactionDiosminAnticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Theoretically, diosmin may increase the risk of bleeding if used with anticoagulant or antiplatelet drugs.
Read the full Diosmin + Abciximab interactionAbemaciclibVerzenio
How Abemaciclib interacts with Venous Support — through 1 ingredient. Tap an ingredient for the detail:
DiosminCytochrome P450 3a4 (cyp3a4) Substrates Moderate
Interaction Summary
Theoretically, diosmin might inhibit the metabolism of CYP3A4 substrates.
Read the full Diosmin + Abemaciclib interactionAbiraterone
How Abiraterone interacts with Venous Support — through 1 ingredient. Tap an ingredient for the detail:
DiosminCytochrome P450 3a4 (cyp3a4) Substrates Moderate
Interaction Summary
Theoretically, diosmin might inhibit the metabolism of CYP3A4 substrates.
Read the full Diosmin + Abiraterone interactionAbiraterone AcetateYonsa, Zytiga
How Abiraterone Acetate interacts with Venous Support — through 1 ingredient. Tap an ingredient for the detail:
DiosminCytochrome P450 3a4 (cyp3a4) Substrates Moderate
Interaction Summary
Theoretically, diosmin might inhibit the metabolism of CYP3A4 substrates.
Read the full Diosmin + Abiraterone Acetate interactionAbrocitinibCibinqo
How Abrocitinib interacts with Venous Support — through 2 ingredients. Tap an ingredient for the detail:
HesperidinAnticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Theoretically, hesperidin may increase the risk of bleeding if used with anticoagulant or antiplatelet drugs.
Read the full Hesperidin + Abrocitinib interactionDiosminAnticoagulant/antiplatelet Drugs, Cytochrome P450 2c9 (cyp2c9) Substrates Moderate
Interaction Summary
Theoretically, diosmin may increase the risk of bleeding if used with anticoagulant or antiplatelet drugs.
Read the full Diosmin + Abrocitinib interactionAcalabrutinibCalquence
How Acalabrutinib interacts with Venous Support — through 2 ingredients. Tap an ingredient for the detail:
HesperidinP-glycoprotein Substrates Moderate
Interaction Summary
Theoretically, hesperidin might inhibit P-glycoprotein-mediated drug efflux and potentially increase levels of drugs that are substrates of P-glycoprotein.
Read the full Hesperidin + Acalabrutinib interactionDiosminCytochrome P450 3a4 (cyp3a4) Substrates, P-glycoprotein Substrates Moderate
Interaction Summary
Theoretically, diosmin might inhibit the metabolism of CYP3A4 substrates.
Read the full Diosmin + Acalabrutinib interactionAcebutololRhotral, Sectral
How Acebutolol interacts with Venous Support — through 1 ingredient. Tap an ingredient for the detail:
HesperidinAntihypertensive Drugs Moderate
Interaction Summary
Theoretically, taking hesperidin with antihypertensive drugs might increase the risk of hypotension.
Read the full Hesperidin + Acebutolol interactionAcenocoumarolSintrom
How Acenocoumarol interacts with Venous Support — through 2 ingredients. Tap an ingredient for the detail:
HesperidinAnticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Theoretically, hesperidin may increase the risk of bleeding if used with anticoagulant or antiplatelet drugs.
Read the full Hesperidin + Acenocoumarol interactionDiosminAnticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Theoretically, diosmin may increase the risk of bleeding if used with anticoagulant or antiplatelet drugs.
Read the full Diosmin + Acenocoumarol interactionAcepromazineAtravet
How Acepromazine interacts with Venous Support — through 1 ingredient. Tap an ingredient for the detail:
HesperidinCns Depressants Moderate
Interaction Summary
Theoretically, concomitant use with CNS depressants may cause additive sedative effects.
Read the full Hesperidin + Acepromazine interactionAcetaminophenChildren's Tylenol, Children's Tylenol Meltaways, Tylenol, Tylenol Ex Strength
How Acetaminophen interacts with Venous Support — through 1 ingredient. Tap an ingredient for the detail:
DiosminCytochrome P450 2e1 (cyp2e1) Substrates Moderate
Interaction Summary
Theoretically, diosmin might inhibit the metabolism of CYP2E1 substrates.
Read the full Diosmin + Acetaminophen interactionAcetaminophen, AspirinGemnisyn
How Acetaminophen, Aspirin interacts with Venous Support — through 2 ingredients. Tap an ingredient for the detail:
DiosminAnticoagulant/antiplatelet Drugs, Cytochrome P450 2e1 (cyp2e1) Substrates Moderate
Interaction Summary
Theoretically, diosmin may increase the risk of bleeding if used with anticoagulant or antiplatelet drugs.
Read the full Diosmin + Acetaminophen, Aspirin interactionHesperidinAnticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Theoretically, hesperidin may increase the risk of bleeding if used with anticoagulant or antiplatelet drugs.
Read the full Hesperidin + Acetaminophen, Aspirin interactionAcetaminophen, Aspirin, CaffeineExcedrin, Excedrin Extra Strength, Excedrin Migraine
How Acetaminophen, Aspirin, Caffeine interacts with Venous Support — through 2 ingredients. Tap an ingredient for the detail:
HesperidinAnticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Theoretically, hesperidin may increase the risk of bleeding if used with anticoagulant or antiplatelet drugs.
Read the full Hesperidin + Acetaminophen, Aspirin, Caffeine interactionDiosminAnticoagulant/antiplatelet Drugs, Cytochrome P450 2e1 (cyp2e1) Substrates +1 Moderate
Interaction Summary
Theoretically, diosmin may increase the risk of bleeding if used with anticoagulant or antiplatelet drugs.
Read the full Diosmin + Acetaminophen, Aspirin, Caffeine interactionAcetaminophen, Brompheniramine, PhenylpropanolamineDimetapp Cold and Flu
How Acetaminophen, Brompheniramine, Phenylpropanolamine interacts with Venous Support — through 1 ingredient. Tap an ingredient for the detail:
DiosminCytochrome P450 2e1 (cyp2e1) Substrates Moderate
Interaction Summary
Theoretically, diosmin might inhibit the metabolism of CYP2E1 substrates.
Read the full Diosmin + Acetaminophen, Brompheniramine, Phenylpropanolamine interactionAcetaminophen, ButalbitalAxocet, Bancap, Bucet, Butex Forte, Esgic CF, Orbivan CF +5 more
How Acetaminophen, Butalbital interacts with Venous Support — through 1 ingredient. Tap an ingredient for the detail:
DiosminCytochrome P450 2e1 (cyp2e1) Substrates Moderate
Interaction Summary
Theoretically, diosmin might inhibit the metabolism of CYP2E1 substrates.
Read the full Diosmin + Acetaminophen, Butalbital interactionAcetaminophen, Butalbital, CaffeineEsgic, Esgic Plus, Fiogesic, Fioricet, Repan, Tecnal +1 more
How Acetaminophen, Butalbital, Caffeine interacts with Venous Support — through 1 ingredient. Tap an ingredient for the detail:
DiosminCytochrome P450 2e1 (cyp2e1) Substrates, Cytochrome P450 3a4 (cyp3a4) Substrates Moderate
Interaction Summary
Theoretically, diosmin might inhibit the metabolism of CYP2E1 substrates.
Read the full Diosmin + Acetaminophen, Butalbital, Caffeine interactionAcetaminophen, Butalbital, Caffeine, CodeineEsgic with Codeine, Fioricet w/ Codeine
How Acetaminophen, Butalbital, Caffeine, Codeine interacts with Venous Support — through 2 ingredients. Tap an ingredient for the detail:
DiosminCytochrome P450 3a4 (cyp3a4) Substrates, Cytochrome P450 2e1 (cyp2e1) Substrates Moderate
Interaction Summary
Theoretically, diosmin might inhibit the metabolism of CYP3A4 substrates.
Read the full Diosmin + Acetaminophen, Butalbital, Caffeine, Codeine interactionHesperidinCns Depressants Moderate
Interaction Summary
Theoretically, concomitant use with CNS depressants may cause additive sedative effects.
Read the full Hesperidin + Acetaminophen, Butalbital, Caffeine, Codeine interactionAcetaminophen, Butalbital, CodeineBancap w/ Codeine
How Acetaminophen, Butalbital, Codeine interacts with Venous Support — through 2 ingredients. Tap an ingredient for the detail:
HesperidinCns Depressants Moderate
Interaction Summary
Theoretically, concomitant use with CNS depressants may cause additive sedative effects.
Read the full Hesperidin + Acetaminophen, Butalbital, Codeine interactionDiosminCytochrome P450 2e1 (cyp2e1) Substrates Moderate
Interaction Summary
Theoretically, diosmin might inhibit the metabolism of CYP2E1 substrates.
Read the full Diosmin + Acetaminophen, Butalbital, Codeine interactionAcetaminophen, Butalbital, Codeine PhosphatePhrenilin #3
How Acetaminophen, Butalbital, Codeine Phosphate interacts with Venous Support — through 2 ingredients. Tap an ingredient for the detail:
DiosminCytochrome P450 2e1 (cyp2e1) Substrates Moderate
Interaction Summary
Theoretically, diosmin might inhibit the metabolism of CYP2E1 substrates.
Read the full Diosmin + Acetaminophen, Butalbital, Codeine Phosphate interactionHesperidinCns Depressants Moderate
Interaction Summary
Theoretically, concomitant use with CNS depressants may cause additive sedative effects.
Read the full Hesperidin + Acetaminophen, Butalbital, Codeine Phosphate interactionAcetaminophen, Caffeine, Chlorpheniramine, Hydrocodone, PhenylephrineHycomine Compound
How Acetaminophen, Caffeine, Chlorpheniramine, Hydrocodone, Phenylephrine interacts with Venous Support — through 2 ingredients. Tap an ingredient for the detail:
HesperidinCns Depressants Moderate
Interaction Summary
Theoretically, concomitant use with CNS depressants may cause additive sedative effects.
Read the full Hesperidin + Acetaminophen, Caffeine, Chlorpheniramine, Hydrocodone, Phenylephrine interactionDiosminCytochrome P450 2e1 (cyp2e1) Substrates, Cytochrome P450 3a4 (cyp3a4) Substrates Moderate
Interaction Summary
Theoretically, diosmin might inhibit the metabolism of CYP2E1 substrates.
Read the full Diosmin + Acetaminophen, Caffeine, Chlorpheniramine, Hydrocodone, Phenylephrine interactionAcetaminophen, Caffeine, CodeineGesic C15, Gesic C30, Gesic C8, Lenoltec 1, Lenoltec 2, Lenoltec 3 +1 more
How Acetaminophen, Caffeine, Codeine interacts with Venous Support — through 2 ingredients. Tap an ingredient for the detail:
DiosminCytochrome P450 3a4 (cyp3a4) Substrates, Cytochrome P450 2e1 (cyp2e1) Substrates Moderate
Interaction Summary
Theoretically, diosmin might inhibit the metabolism of CYP3A4 substrates.
Read the full Diosmin + Acetaminophen, Caffeine, Codeine interactionHesperidinCns Depressants Moderate
Interaction Summary
Theoretically, concomitant use with CNS depressants may cause additive sedative effects.
Read the full Hesperidin + Acetaminophen, Caffeine, Codeine interactionAcetaminophen, Caffeine, Codeine, SalicylamideCodalan No.1, Codalan No.2, Codalan No.3
How Acetaminophen, Caffeine, Codeine, Salicylamide interacts with Venous Support — through 2 ingredients. Tap an ingredient for the detail:
DiosminCytochrome P450 3a4 (cyp3a4) Substrates, Cytochrome P450 2e1 (cyp2e1) Substrates Moderate
Interaction Summary
Theoretically, diosmin might inhibit the metabolism of CYP3A4 substrates.
Read the full Diosmin + Acetaminophen, Caffeine, Codeine, Salicylamide interactionHesperidinCns Depressants Moderate
Interaction Summary
Theoretically, concomitant use with CNS depressants may cause additive sedative effects.
Read the full Hesperidin + Acetaminophen, Caffeine, Codeine, Salicylamide interactionAcetaminophen, Caffeine, DihydrocodeineDHC Plus, Panlor DC, Panlor SS
How Acetaminophen, Caffeine, Dihydrocodeine interacts with Venous Support — through 2 ingredients. Tap an ingredient for the detail:
HesperidinCns Depressants Moderate
Interaction Summary
Theoretically, concomitant use with CNS depressants may cause additive sedative effects.
Read the full Hesperidin + Acetaminophen, Caffeine, Dihydrocodeine interactionDiosminCytochrome P450 2e1 (cyp2e1) Substrates, Cytochrome P450 3a4 (cyp3a4) Substrates Moderate
Interaction Summary
Theoretically, diosmin might inhibit the metabolism of CYP2E1 substrates.
Read the full Diosmin + Acetaminophen, Caffeine, Dihydrocodeine interactionAcetaminophen, Caffeine, IsomethepteneMigralam
How Acetaminophen, Caffeine, Isometheptene interacts with Venous Support — through 1 ingredient. Tap an ingredient for the detail:
DiosminCytochrome P450 3a4 (cyp3a4) Substrates, Cytochrome P450 2e1 (cyp2e1) Substrates Moderate
Interaction Summary
Theoretically, diosmin might inhibit the metabolism of CYP3A4 substrates.
Read the full Diosmin + Acetaminophen, Caffeine, Isometheptene interactionAcetaminophen, Caffeine, PyrilamineMidol Max Strength Menstrual
How Acetaminophen, Caffeine, Pyrilamine interacts with Venous Support — through 1 ingredient. Tap an ingredient for the detail:
DiosminCytochrome P450 2e1 (cyp2e1) Substrates, Cytochrome P450 3a4 (cyp3a4) Substrates Moderate
Interaction Summary
Theoretically, diosmin might inhibit the metabolism of CYP2E1 substrates.
Read the full Diosmin + Acetaminophen, Caffeine, Pyrilamine interactionAcetaminophen, Chlorpheniramine Maleate, Dextromethorphan HbrVicks Formula 44M Cough, Cold & Flu Relief
How Acetaminophen, Chlorpheniramine Maleate, Dextromethorphan Hbr interacts with Venous Support — through 1 ingredient. Tap an ingredient for the detail:
DiosminCytochrome P450 2e1 (cyp2e1) Substrates, Cytochrome P450 3a4 (cyp3a4) Substrates Moderate
Interaction Summary
Theoretically, diosmin might inhibit the metabolism of CYP2E1 substrates.
Read the full Diosmin + Acetaminophen, Chlorpheniramine Maleate, Dextromethorphan Hbr interactionAcetaminophen, Chlorpheniramine, Codeine, PhenylephrineColrex
How Acetaminophen, Chlorpheniramine, Codeine, Phenylephrine interacts with Venous Support — through 2 ingredients. Tap an ingredient for the detail:
HesperidinCns Depressants Moderate
Interaction Summary
Theoretically, concomitant use with CNS depressants may cause additive sedative effects.
Read the full Hesperidin + Acetaminophen, Chlorpheniramine, Codeine, Phenylephrine interactionDiosminCytochrome P450 3a4 (cyp3a4) Substrates, Cytochrome P450 2e1 (cyp2e1) Substrates Moderate
Interaction Summary
Theoretically, diosmin might inhibit the metabolism of CYP3A4 substrates.
Read the full Diosmin + Acetaminophen, Chlorpheniramine, Codeine, Phenylephrine interactionAcetaminophen, Chlorpheniramine, DextromethorphanCoricidin II Extra Strength Cold and Flu
How Acetaminophen, Chlorpheniramine, Dextromethorphan interacts with Venous Support — through 1 ingredient. Tap an ingredient for the detail:
DiosminCytochrome P450 2e1 (cyp2e1) Substrates, Cytochrome P450 3a4 (cyp3a4) Substrates Moderate
Interaction Summary
Theoretically, diosmin might inhibit the metabolism of CYP2E1 substrates.
Read the full Diosmin + Acetaminophen, Chlorpheniramine, Dextromethorphan interactionAcetaminophen, Chlorpheniramine, Dextromethorphan HydrobromideCoricidin HBP Maximum Strength Flu
How Acetaminophen, Chlorpheniramine, Dextromethorphan Hydrobromide interacts with Venous Support — through 1 ingredient. Tap an ingredient for the detail:
DiosminCytochrome P450 3a4 (cyp3a4) Substrates, Cytochrome P450 2e1 (cyp2e1) Substrates Moderate
Interaction Summary
Theoretically, diosmin might inhibit the metabolism of CYP3A4 substrates.
Read the full Diosmin + Acetaminophen, Chlorpheniramine, Dextromethorphan Hydrobromide interactionAcetaminophen, Chlorpheniramine, Dextromethorphan, PhenylpropanolamineMulti Symptom Cold Relief
How Acetaminophen, Chlorpheniramine, Dextromethorphan, Phenylpropanolamine interacts with Venous Support — through 1 ingredient. Tap an ingredient for the detail:
DiosminCytochrome P450 2e1 (cyp2e1) Substrates, Cytochrome P450 3a4 (cyp3a4) Substrates Moderate
Interaction Summary
Theoretically, diosmin might inhibit the metabolism of CYP2E1 substrates.
Read the full Diosmin + Acetaminophen, Chlorpheniramine, Dextromethorphan, Phenylpropanolamine interactionEach ingredient & the kinds of drugs it affects
For each ingredient in Venous Support with known interactions, here are the types of medications they can affect. Open any type for the detail — or search your exact drug in the checker above.
Diosmin
Anticoagulant/Antiplatelet Drugs
Theoretically, diosmin may increase the risk of bleeding if used with anticoagulant or antiplatelet drugs.
A case of spontaneous intraventricular hemorrhage has been reported for a 77-year-old female after 6 weeks of warfarin therapy, despite an international normalized ratio (INR) of only 1.8. The patient had also been taking aspirin and diosmin for several years. Experts speculate that chronic intake of diosmin predisposed the patient to spontaneous intraventricular hemorrhage by inducing chronic microcirculatory hypertension and inhibiting platelet aggregation. The presence of aspirin was also thought to play a role in this event.
Carbamazepine (Tegretol)
Theoretically, diosmin might reduce the effects of carbamazepine and increase the risk for convulsions.
A pharmacokinetic study in humans shows that taking diosmin (Venex) 500 mg daily for 10 days prior to oral administration of carbamazepine 200 mg increases blood levels of carbamazepine by approximately 58% and decreases carbamazepine clearance by 42%. It also decreases the formation of carbamazepine's active metabolite. It is speculated that diosmin reduces the metabolism of carbamazepine by inhibiting cytochrome P450 3A4 (CYP3A4).
Chlorzoxazone (Parafon Forte, Paraflex)
Theoretically, diosmin might increase the levels and clinical effects of chlorzoxazone.
A pharmacokinetic study in humans shows that taking diosmin (Venex 500) 500 mg daily for 9 days prior to oral administration of chlorzoxazone 250 mg increases blood levels of chlorzoxazone by 53% and decreases chlorzoxazone clearance by 40%. It is speculated that diosmin reduces the metabolism of chlorzoxazone by inhibiting cytochrome P450 2E1 (CYP2E1).
Cytochrome P450 2C9 (Cyp2C9) Substrates
Theoretically, diosmin might inhibit the metabolism of CYP2C9 substrates.
Diclofenac is metabolized by CYP2C9 enzymes. Clinical and laboratory research shows that diosmin inhibits the metabolism of diclofenac. A pharmacokinetic study in humans shows that taking diosmin (Venex 500) 500 mg daily for 9 days prior to oral administration of diclofenac 100 mg increases blood levels of diclofenac and decreases diclofenac clearance.
Cytochrome P450 2E1 (Cyp2E1) Substrates
Theoretically, diosmin might inhibit the metabolism of CYP2E1 substrates.
Chlorzoxazone is metabolized by CYP2E1 enzymes. A pharmacokinetic study in humans shows that taking diosmin (Venex 500) 500 mg daily for 9 days prior to oral administration of chlorzoxazone (Paraflex 250) 250 mg increases blood levels of chlorzoxazone by 34% and decreases chlorzoxazone clearance by 40%. It is speculated that diosmin reduces the metabolism of chlorzoxazone by inhibiting CYP2E1.
Cytochrome P450 3A4 (Cyp3A4) Substrates
Theoretically, diosmin might inhibit the metabolism of CYP3A4 substrates.
Laboratory research is conflicting with respect to the effects of diosmin on CYP3A4. Some research suggests that diosmin does not affect CYP3A4 activity. However, other research suggests that diosmin alters the metabolism of carbamazepine, a CYP3A4 substrate. Laboratory and animal research show that oral administration of diosmin for 7 days prior to oral administration of carbamazepine increases plasma concentrations of carbamazepine, decreases the clearance of carbamazepine, and decreases the formation of carbamazepine's active metabolite. Additionally, pharmacokinetic research in healthy male subjects shows that taking diosmin (Venex) 500 mg daily for 10 days prior to oral administration of carbamazepine 200 mg increases blood levels of carbamazepine by approximately 58% and decreases carbamazepine clearance by 42%. It is speculated that diosmin reduces the metabolism of carbamazepine by inhibiting CYP3A4. Diosmetin, a metabolite of diosmin, may also inhibit CYP3A4.
Diclofenac (Voltaren, Others)
Theoretically, diosmin might increase the levels and clinical effects of diclofenac.
Clinical and laboratory research shows that diosmin inhibits the metabolism of diclofenac. A pharmacokinetic study in humans shows that taking diosmin (Venex 500) 500 mg daily for 9 days prior to oral administration of diclofenac 100 mg increases blood levels of diclofenac and decreases diclofenac clearance. It is speculated that diosmin reduces the metabolism of diclofenac by inhibiting cytochrome P450 2C9 (CYP2C9).
Fexofenadine (Allegra)
Theoretically, diosmin might increase the levels and clinical effects of fexofenadine.
A pharmacokinetic study in humans shows that taking diosmin (Venex) 500 mg daily for 10 days prior to oral administration of fexofenadine 120 mg increases blood levels of fexofenadine by approximately 49% and decreases the apparent oral clearance of fexofenadine by 41%. The time taken to reach maximum plasma concentration, the half-life, and the apparent renal clearance of fexofenadine are not affected. For this reason, it is speculated that diosmin alters the pharmacokinetics of fexofenadine via inhibition of P-glycoprotein in the intestine, but not in the kidney or liver.
P-Glycoprotein Substrates
Theoretically, diosmin might increase levels of drugs that are substrates of P-glycoprotein (P-gp).
Preliminary laboratory research suggests that diosmin inhibits P-gp. Additionally, pharmacokinetic research in healthy male subjects shows that taking diosmin (Venex) 500 mg daily for 10 days prior to oral administration of fexofenadine 120 mg increases blood levels of fexofenadine, a P-gp substrate, by approximately 49% and decreases the apparent oral clearance of fexofenadine by 41%. The time taken to reach maximum plasma concentration, the half-life, and the apparent renal clearance of fexofenadine are not affected. For this reason, it is speculated that diosmin inhibits P-gp in the intestine, but not in the kidney or liver.
Hesperidin
Anticoagulant/Antiplatelet Drugs
Theoretically, hesperidin may increase the risk of bleeding if used with anticoagulant or antiplatelet drugs.
Animal research suggests that hesperetin, a bioflavonoid aglycone derivative of hesperidin, may have antiplatelet activity.
Antihypertensive Drugs
Theoretically, taking hesperidin with antihypertensive drugs might increase the risk of hypotension.
Some clinical and animal research shows that hesperidin can decrease blood pressure. However, other clinical research shows that hesperidin does not affect blood pressure.
Celiprolol (Celicard)
Theoretically, hesperidin may decrease the levels and clinical effects of celiprolol.
Animal research shows that concomitant use of hesperidin may reduce the plasma area under the curve of celiprolol by up to 75%. This effect has not been reported in humans.
Cns Depressants
Theoretically, concomitant use with CNS depressants may cause additive sedative effects.
Animal studies show that hesperidin has sedative effects, due to opioid receptor activity and can increase sedation when used with diazepam. This effect has not been reported in humans.
Diltiazem (Cardizem, Others)
Theoretically, hesperidin may increase the levels and clinical effects of diltiazem.
Animal research suggests that hesperidin may enhance the bioavailability of diltiazem, increasing the plasma area under the curve of diltiazem by up to 65.3%. This effect has not been reported in humans.
P-Glycoprotein Substrates
Theoretically, hesperidin might inhibit P-glycoprotein-mediated drug efflux and potentially increase levels of drugs that are substrates of P-glycoprotein.
In vitro research shows that hesperidin can inhibit P-glycoprotein efflux. This effect has not been reported in humans.
Verapamil (Calan, Others)
Theoretically, hesperidin might increase the levels and clinical effects of verapamil.
Animal research suggests that hesperidin may enhance the bioavailability of verapamil, increasing the plasma area under the curve of verapamil by 96.8%. This effect has not been reported in humans
Brand information
Manufacturer and brand details for Venous Support, from the product label.
Progressive Professional from Progressive Laboratories
See all Progressive Professional from Progressive Laboratories products- Name
- Progressive Laboratories, Inc.
- City
- Irving
- State
- Texas
- ZipCode
- 75038
- Phone Number
- 1-800-527-9512
Venous Support by Progressive Professional from Progressive Laboratories: Common Questions
Does Venous Support by Progressive Professional from Progressive Laboratories interact with any medications?
How can one product interact with so many drugs?
Where does this information come from?
Can I take this if I'm pregnant or breastfeeding?
What side effects might I experience?
How long can I safely take this supplement?
Does olive leaf extract interact with medications?
Why is diosmin in a supplement for veins?
Can this help my cholesterol or weight?
Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy
Not sure if Venous Support is safe with your meds?
Our pharmacists answer your medication & supplement questions — free.
Label information is sourced from the NIH Dietary Supplement Label Database and reflects the product version on file; always read your actual product label. This page is for education only and is not a substitute for professional medical advice. Confirm with your pharmacist or doctor before combining supplements and medications.
The Full Monographs Behind Venous Support’s Ingredients
Every ingredient we hold a full HelloPharmacist monograph for — uses, evidence, safety, and the complete interaction list.
Olive
Olive comes from the same tree that gives us olives and olive oil, and its leaf and fruit contain antioxidant compounds like oleuropein and hydroxytyrosol. Olive oil as part of a Mediterrane...
Read the full Olive monograph → Herb & supplement monographDiosmin
Interacts with 884 drugsDiosmin is a citrus-derived flavonoid most often used for vein-related problems such as chronic venous insufficiency and hemorrhoids, and it is usually combined with a related flavonoid call...
Read the full Diosmin monograph → Herb & supplement monographHesperidin
Interacts with 702 drugsHesperidin is a flavonoid found in citrus fruits that is often combined with diosmin and used for vein and circulation problems like hemorrhoids and varicose veins. Some evidence supports th...
Read the full Hesperidin monograph →Sources & How We Checked
Venous Support's label data comes from the NIH Dietary Supplement Label Database; the ingredient interaction data is from the Natural Medicines database, reviewed by our pharmacists.
- NIH Dietary Supplement Label Database (DSLD) — The official product label on file for this supplement.
- Natural Medicines (Therapeutic Research Center) — Evidence-graded clinical reference behind the ingredient interaction data.
Content is written and reviewed by licensed HelloPharmacist pharmacists. See our data sources and editorial standards for how this information is built and checked.
The 36 references behind this product’s interaction data
Every citation that drives the interaction findings for this product’s ingredients, from the evidence-graded Natural Medicines (TRC Healthcare) database. Open an ingredient to browse its citations — links open the study on PubMed or the publisher’s site.
Olive 2 references
- Liccardi G, D'Amato M, D'Amato G. Oleaceae pollinosis: a review. Int Arch Allergy Immunol 1996;111:210-7. PubMed
- Somerville V, Moore R, Braakhuis A. The effect of olive leaf extract on upper respiratory illness in high school athletes: A randomised control trial. Nutrients. 2019;11(2). pii: E358. PubMed
Diosmin 20 references
- Misra MC, Parshad R. Randomized clinical trial of micronized flavonoids in the early control of bleeding from acute internal haemorrhoids. Br J Surgery 2000;87:868-72. PubMed
- Thanapongsathorn W, Vajrabukka T. Clinical trial of oral diosmin (Daflon) in the treatment of hemorrhoids. Dis Colon Rectum 1992;35:1085-8. PubMed
- Cospite M. Double-blind, placebo-controlled evaluation of clinical activity and safety of Daflon 500 mg in the treatment of acute hemorrhoids. Angiology 1994;45:566-73.
- Guilhou JJ, Dereure O, Marzin L, et al. Efficacy of Daflon 500 mg in venous leg ulcer healing: a double-blind, randomized, controlled versus placebo trial in 107 patients. Angiology 1997;48:77-85.. PubMed
- Cospite, M. and Dominici, A. Double blind study of the pharmacodynamic and clinical activities of 5682 SE in venous insufficiency. Advantages of the new micronized form. Int Angiol. 1989;8(4 Suppl):61-65.
- Buckshee, K., Takkar, D., and Aggarwal, N. Micronized flavonoid therapy in internal hemorrhoids of pregnancy. Int J Gynaecol Obstet 1997;57(2):145-151. PubMed
- Kumar RM, Van Gompel JJ, Bower R, Rabinstein AA. Spontaneous intraventricular hemorrhage associated with prolonged diosmin therapy. Neurocrit Care. 2011 Jun;14(3):438-40. PubMed
- Milano G, Leone S, Fucile C, Zuccoli ML, Stimamiglio A, Martelli A, Mattioli F. Uncommon serum creatine phosphokinase and lactic dehydrogenase increase during diosmin therapy: two case reports. J Med Case Rep. 2014 Jun 16;8:194. PubMed
- Rajnarayana K, Venkatesham A, Krishna DR. Bioavailability of diclofenac sodium after pretreatment with diosmin in healthy volunteers. Drug Metabol Drug Interact. 2007;22(2-3):165-74. PubMed
- Rajnarayana K, Venkatesham A, Nagulu M, Srinivas M, Krishna DR. Influence of diosmin pretreatment on the pharmacokinetics of chlorzoxazone in healthy male volunteers. Drug Metabol Drug Interact. 2008;23(3-4):311-21. PubMed
- Yoo HH, Lee M, Chung HJ, Lee SK, Kim DH. Effects of diosmin, a flavonoid glycoside in citrus fruits, on P-glycoprotein-mediated drug efflux in human intestinal Caco-2 cells. J Agric Food Chem. 2007 Sep 5;55(18):7620-5. PubMed
- Bedada SK, Neerati P. Modulation of CYP3A enzyme activity by diosmin and its consequence on carbamazepine pharmacokinetics in rats. Naunyn Schmiedebergs Arch Pharmacol. 2018;391(2):115-21. PubMed
- Burkina V, Zlabek V, Halsne R, Ropstad E, Zamaratskaia G. In vitro effects of the citrus flavonoids diosmin, naringenin and naringin on the hepatic drug-metabolizing CYP3A enzyme in human, pig, mouse and fish. Biochem Pharmacol. 2016;110-111:109-16 PubMed
- Bedada SK, Boga PK. Influence of diosmin on the metabolism and disposition of carbamazepine in healthy subjects. Xenobiotica. 2017;47(10):879-84. PubMed
- Bedada SK, Boga PK, Kotakonda HK. The effect of diosmin on the pharmacokinetics of fexofenadine in healthy human volunteers. Xenobiotica. 2017;47(3):230-35. PubMed
- Poór M, Boda G, Mohos V, et al. Pharmacokinetic interaction of diosmetin and silibinin with other drugs: Inhibition of CYP2C9-mediated biotransformation and displacement from serum albumin. Biomed Pharmacother. 2018;102:912-921. PubMed
- Gavrilov SG, Karalkin AV, Moskalenko YP, Grishenkova AS. Efficacy of two micronized purified flavonoid fraction dosing regimens in the pelvic venous pain relief. Int Angiol. 2021;40(3):180-186. PubMed
- Steinbruch M, Nunes C, Gama R, et al. Is nonmicronized diosmin 600?mg as effective as micronized diosmin 900?mg plus hesperidin 100?mg on chronic venous disease symptoms? Results of a noninferiority study. Int J Vasc Med. 2020;2020:4237204. PubMed
- Schastlivtsev I, Lobastov K, Barinov V, Kanzafarova I. Diosmin 600 in adjunction to rivaroxaban reduces the risk of post-thrombotic syndrome after femoropopliteal deep vein thrombosis: results of the RIDILOTT DVT study. Int Angiol. 2020;39(5):361-371. PubMed
- Mansilha A, Caldevilla H, Puskás A, Lucien A, Roby L, Kirienko A. MPFF 1000 mg chewable once daily vs. MPFF 500 mg twice daily in chronic venous disease: the double-blind, randomized, non-inferiority CHEWY trial. Int Angiol 2022;41(6):464-475. PubMed
Hesperidin 14 references
- Fernandez, S. P., Wasowski, C., Paladini, A. C., and Marder, M. Synergistic interaction between hesperidin, a natural flavonoid, and diazepam. Eur.J.Pharmacol. 4-11-2005;512(2-3):189-198. PubMed
- Jin, Y. R., Han, X. H., Zhang, Y. H., Lee, J. J., Lim, Y., Chung, J. H., and Yun, Y. P. Antiplatelet activity of hesperetin, a bioflavonoid, is mainly mediated by inhibition of PLC-gamma2 phosphorylation and cyclooxygenase-1 activity. Atherosclerosis 200
- Loscalzo, L. M., Wasowski, C., Paladini, A. C., and Marder, M. Opioid receptors are involved in the sedative and antinociceptive effects of hesperidin as well as in its potentiation with benzodiazepines. Eur.J.Pharmacol. 2-12-2008;580(3):306-313. PubMed
- Yamamoto, M., Suzuki, A., Jokura, H., Yamamoto, N., and Hase, T. Glucosyl hesperidin prevents endothelial dysfunction and oxidative stress in spontaneously hypertensive rats. Nutrition 2008;24(5):470-476. PubMed
- El-Readi, M. Z., Hamdan, D., Farrag, N., El-Shazly, A., and Wink, M. Inhibition of P-glycoprotein activity by limonin and other secondary metabolites from Citrus species in human colon and leukaemia cell lines. Eur.J.Pharmacol. 1-25-2010;626(2-3):139-145 PubMed
- Buckshee, K., Takkar, D., and Aggarwal, N. Micronized flavonoid therapy in internal hemorrhoids of pregnancy. Int J Gynaecol Obstet 1997;57(2):145-151. PubMed
- Uesawa, Y. and Mohri, K. Hesperidin in orange juice reduces the absorption of celiprolol in rats. Biopharm Drug Dispos. 2008;29(3):185-188. PubMed
- Cho, YA, Choi, DH, and Choi, JS. Effect of hesperidin on the oral pharmacokinetics of diltiazem and its main metabolite, desacetyldiltiazem, in rats. J Pharm Pharmacol. 2009;61(6):825-829. PubMed
- Piao, YJ and Choi, JS. Enhanced bioavailability of verapamil after oral administration with hesperidin in rats. Arch Pharm Res. 2008;31(4):518-522. PubMed
- Andersen KE. Hesperidin methyl chalcone?-?a new cosmetic contact allergen. Contact Dermatitis. 2015;72(6):402-4. PubMed
- Morand C, Dubray C, Milenkovic D, et al. Hesperidin contributes to the vascular protective effects of orange juice: a randomized crossover study in healthy volunteers. Am J Clin Nutr 2011;93(1):73-80. PubMed
- Homayouni F, Haidari F, Hedayati M, Zakerkish M, Ahmadi K. Blood pressure lowering and anti-inflammatory effects of hesperidin in type 2 diabetes; a randomized double-blind controlled clinical trial. Phytother Res. 2018;32(6):1073-1079. PubMed
- Mohammadi M, Ramezani-Jolfaie N, Lorzadeh E, Khoshbakht Y, Salehi-Abargouei A. Hesperidin, a major flavonoid in orange juice, might not affect lipid profile and blood pressure: A systematic review and meta-analysis of randomized controlled clinical trials PubMed
- Valls RM, Pedret A, Calderón-Pérez L, et al. Effects of hesperidin in orange juice on blood and pulse pressures in mildly hypertensive individuals: a randomized controlled trial (Citrus study). Eur J Nutr. 2021;60(3):1277-1288. PubMed
Parts of this content are provided by the Therapeutic Research Center, LLC.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC